SLIDE 1
Agenda
Introduction to Concateno Airline Experience Implementing a Policy Drug testing options Support Services
Presentation to U.K. Flight Safety Committee Drug & Alcohol - - PowerPoint PPT Presentation
Presentation to U.K. Flight Safety Committee Drug & Alcohol - - PowerPoint PPT Presentation
Presentation to U.K. Flight Safety Committee Drug & Alcohol Testing 9 th March 2010 Bill Percy Agenda Introduction to Concateno Airline Experience Implementing a Policy Drug testing options Support Services Concateno Plc
SLIDE 2
SLIDE 3
Concateno Plc
- The Leading Provider of Drug & Alcohol Testing
Services
- Highest levels of Accreditation and Quality Assurance
- 11 Million Drug Tests per annum
- Over 8,000 Customers
- Over 300 Staff
- International Collection Network of over 500 officers
- Public Limited Company (London AIM)
- £50m Turnover (forecast ’08)
SLIDE 4
Airline Experience
Emirates VAA BA Qantas Bmi Ryan Air My Travel easyJet
SLIDE 5
Implementing a Policy
Considerate Implementation Managerial training packages Employee Communication Newsletters Staff associations Payslips Notice boards Education & awareness material
SLIDE 6
Testing – the Options
SLIDE 7
Breath
Lion SD400P alcometers Evidential & legally defensible Supported by breath test record Collecting Officer accreditation Quick & reliable
SLIDE 8
Urine
3 – 4 day detection window (average) high concentration of drug large sample volume Used in regulated industries
E.g. Rail, Maritime, Oil, Transport
Established cut off levels Highly researched & accepted 2 stage process Instant or BTL
SLIDE 9
Oral fluid
12 hour – 24 hour day detection window non invasive collect single sample that is split – IDENTICAL
Avoids collection of 2 non-identical samples
No common cut off levels 2 stage process Instant or BTL
SLIDE 10
Hair
Long detection window (1 cm = 1 month) Longer turn around time – labour intensive testing Common workplace use
Pre-employment, Corroborative
Other uses
Medico-Legal
SLIDE 11
The Testing process
UKAS ISO 17025 Accreditation – QA & QC
- 1. PRIMARY SCREEN – IMMUNOASSAY
- non-specific drug identification
- identifies NEGATIVE specimens
- 2. GC(LC)/MS CONFIRMATION TEST
(Gas (Liquid) Chromatography / Mass Spectrometry)
- compound specific - ‘fingerprint’
- quantitative results
Laboratory or On-site test
SLIDE 12
Medical Review Officer
Capability to provide MRO if required Access to panel of independent MRO’s Good working relationship with Toxicologists
SLIDE 13
Quality Assurance
- Laboratories - UKAS 17025 accreditation
- Robust QA & QC schemes
- Hair - SoHT, GTFCH
- Urine - CAP, UK NEQAS, Link Up, Tackler Analytical
- Oral fluids - Research Triangle International, UK NEQAS
- External Proficiency schemes
SLIDE 14
Random testing
Independence is important Dedicated Programme Manager Varying levels of support offered
Programme Managed Programme Assisted
Day to Day contact & support
SLIDE 15
Collection Teams
500 Collectors globally 150 Collectors in UK UK Collectors directly
employed, trained and audited
UKAS 17025 accredited for
field breath testing
SLIDE 16
Collection Services
For Cause
- Regional teams with overlapping cover
- Team is paged that can give the fastest response
- The ‘clock’ starts from the time agreed at the end
- f your call
- > 98% within 2 hours
- Average response time (2008) = 78 minutes
- 1637 Call outs in ‘06; > 2000 in ‘07
SLIDE 17
Chain of Custody
1 of 3 steps in legally defensible testing Input to CoC protocols through EWDTS Collecting Officers trained & regularly audited
UKAS 17025 accredited for breath testing
Laboratory UKAS 17025 accredited
QA – range of initiatives QC – exhaustive
Not one successfully challenged sample
SLIDE 18
Management Reports
Wide range of data captured by LIMS Agree content of standard reports Ability to create non-standard, bespoke reports Results reporting
Password protected PDF
SLIDE 19